Attovia Therapeutics (ATTO) vs Aura Biosciences (AURA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Attovia Therapeutics is the larger company by market cap ($744.6 million vs $674.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATTO | AURA |
|---|---|---|
| Share price | $16.31 | $6.51 |
| Market cap | $744.57M | $674.60M |
| 1-day change | -0.67% | +0.70% |
| YTD return | — | +19.36% |
| 1-year return | — | +6.81% |
| EPS (TTM) | $-2.74 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.00 | $9.54 |
| 52-week low | $15.48 | $4.73 |
| Distance from 52-week high | -41.75% | -31.78% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +158.74% | +155.19% |
| Average volume | 457.37K | 740.43K |
| Shares outstanding | 45.65M | 103.70M |
| Employees | 44 | 113 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Attovia Therapeutics in Healthcare and Aura Biosciences in Health Care.
About Attovia Therapeutics
ATTO stock →Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.
Healthcare · Biotechnology · 44 employees
About Aura Biosciences
AURA stock →Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 113 employees
ATTO vs AURA FAQ
Which is bigger, Attovia Therapeutics or Aura Biosciences?
Attovia Therapeutics (ATTO) is larger, with a market capitalization of $744.57M compared with $674.60M for Aura Biosciences (AURA).
Are Attovia Therapeutics and Aura Biosciences in the same industry?
No. Attovia Therapeutics is in the Healthcare sector, while Aura Biosciences is in Health Care.